dc.description.abstract |
The field of infectious diseases is ever changing with emerging pathogens, globalization,
growing antimicrobial resistance, expanding therapeutic options and continuous
development of vaccines and strategies for drug implementation. At the present time,
Infectious diseases affects more than one billion people (one-sixth of the world’s population)
with almost 550 000 deaths annually. Malaria, Leishmania and antimycobacterial are
considered to be the one of the most widespread infectious disease. The chemotherapy of
these diseases is still dependent on the drugs got resistance or become ineffective and
several side effects or cost effective. For these reasons, the search for novel molecules with
effective results and resistance resolving efficacy is the prime choice for the medicinal
chemists. Mechanism specific studies of these molecules will be also helpful to overcome
the problem of emerging resistance and chemical modification led to enhance efficacy. Here
we made an attempt for the synthesis of novel heterocycles like 1,3,5-triazine, tetrazole,
rhodanine, quinoline and quinolone and their spiro derivatives, as they have already
established as a safe, effective and promising anti-infective agents and screened for a verity
of infectious diseases |
en_US |